… Email alerts Receive an email notification whenever ProQR issues a new press release. Never miss an important … Subscribe for email alerts Get an email alert every time ProQR issues a press release. Never miss a quarterly report, …
… at the forefront of the Axiomer® technology development. ProQR’s Sr. Vice President Innovation makes his point about … idea and made resources available to perform the necessary R&D work. This was late 2014. The foundation for the Axiomer® …
… publication. Please read our latest community news update: ProQR agreement with Laboratoires Théa for sepofarsen and … Biasutto, born and raised in Venezuela and now heading ProQR’s LCA research and development team in Leiden (The …
… RNA therapies for severe rare and common diseases. ProQR recognizes the importance of advancing diversity, … to fully thrive and to make their maximum contribution to ProQR. ProQR recognizes the importance of advancing …
… Rare Disease Day 2022 On behalf of all ProQRians, happy Rare Disease Day 2022. Both within ProQR and outside, we join the community in raising awareness …
… Analyst and Investor Event on Wednesday, December 11, 2024 ProQR will host a virtual Analyst and Investor Event on … Program and member of the Scientific Advisory Board at ProQR. Prof. Gideon Hirschfield, MA(Oxon) MB BChir (Cantab) … under “Events” in the “Investors & Media” section of ProQR’s website at https://www.proqr.com/events . To join via …
… publication. Please read our latest community news update: ProQR agreement with Laboratoires Théa for sepofarsen and … This was not the outcome we had hoped for Benjamin R. Yerxa, Chief Executive Officer at the Foundation Fighting … Daniel A. de Boer, Founder and CEO of ProQR Therapeutics. “ProQR was founded with the goal of developing RNA therapies …
